title: Respiratory inflammation and infections in high-performance athletes.
abstract: Upper respiratory illness is the most common reason for non-injury-related presentation to a sports medicine clinic, accounting for 35-65% of illness presentations. Recurrent or persistent respiratory illness can have a negative impact on health and performance of athletes undertaking high levels of strenuous exercise. The cause of upper respiratory symptoms (URS) in athletes can be uncertain but the majority of cases are related to common respiratory viruses, viral reactivation, allergic responses to aeroallergens and exercise-related trauma to the integrity of respiratory epithelial membranes. Bacterial respiratory infections are uncommon in athletes. Undiagnosed or inappropriately treated asthma and/or allergy are common findings in clinical assessments of elite athletes experiencing recurrent URS. High-performance athletes with recurrent episodes of URS should undergo a thorough clinical assessment to exclude underlying treatable conditions of respiratory inflammation. Identifying athletes at risk of recurrent URS is important in order to prescribe preventative clinical, training and lifestyle strategies. Monitoring secretion rates and falling concentrations of salivary IgA can identify athletes at risk of URS. Therapeutic interventions are limited by the uncertainty of the underlying cause of inflammation. Topical anti-inflammatory sprays can be beneficial for some athletes. Dietary supplementation with bovine colostrum, probiotics and selected antioxidants can reduce the incidence or severity of URS in some athletes. Preliminary studies on athletes prone to URS indicate a genetic predisposition to a pro-inflammatory response and a dysregulated anti-inflammatory cytokine response to intense exercise as a possible mechanism of respiratory inflammation. This review focuses on respiratory infections and inflammation in elite/professional athletes.
authors.affiliation: Hunter Medical Research Institute and School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, New South Wales, Australia.
authors.forename: Maree
authors.initials: M
authors.lastname: Gleeson
authors.affiliation: Department of Physiology, Sports Science and Medicine, Australian Institute of Sport, Belconnen, Australian Capital Territory, Australia.|Research Institute for Sports and Exercise, University of Canberra, Canberra, Australian Capital Territory, Australia.
authors.forename: David B
authors.initials: DB
authors.lastname: Pyne
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use; D001250:Asthma, Exercise-Induced / Q000276:immunology* / Q000628:therapy; D056352:Athletes; D054874:Athletic Performance; D019587:Dietary Supplements; D015444:Exercise / Q000502:physiology; D006801:Humans; D007249:Inflammation / Q000453:epidemiology / Q000276:immunology / Q000628:therapy; D019936:Probiotics / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000453:epidemiology* / Q000276:immunology* / Q000628:therapy
chemical_list: D000893:Anti-Inflammatory Agents; D000975:Antioxidants